What's Going Around?
Measles
We share your concern regarding the recent outbreaks of measles in the U.S. Thankfully, we have not had reported cases in our immediate area.
We recommend and administer the MMR vaccine at the 12-month-old well child visit, and again at the 4-year-old well child visit. These are the recommendations of every major healthcare organization, including the American Academy of Pediatrics and the Centers for Disease Control. The vaccine is safe and effective, with a measles prevention protection of 93% with the first dose, which increases to 97% measle prevention protection with the second (and final) dose.
If you would like to confirm your child’s vaccination status, please log in to your Advocare Delaware Pediatrics portal account, where you have access to your child’s vaccine record. Our practice has a near 100% on-schedule vaccination rate MMR vaccine, so it would be very unusual if your child is not up to date.
There are situations in which it may be recommended that a child receive the MMR vaccine prior to the 12-Month-old visit, and this is primarily indicated if a child has had direct exposure to a person with the measles , and certain travel situations in which the child will be going to an area with a high prevalence of measles.
The earliest a child can receive the MMR vaccine is 6 months of age. Although vaccinating a child at an age under 12 months has been found to be somewhat effective, protocols which optimize the protective immunity of the MMR vaccine necessitate that a child who receives an MMR vaccine prior to the age of 12 months also then receive the MMR vaccine again at 12 months of age, in order to ensure the greatest likelihood of high protective immunity.
Measles is one of the most contagious diseases on earth. We are monitoring the situation as it evolves.
We recommend and administer the MMR vaccine at the 12-month-old well child visit, and again at the 4-year-old well child visit. These are the recommendations of every major healthcare organization, including the American Academy of Pediatrics and the Centers for Disease Control. The vaccine is safe and effective, with a measles prevention protection of 93% with the first dose, which increases to 97% measle prevention protection with the second (and final) dose.
If you would like to confirm your child’s vaccination status, please log in to your Advocare Delaware Pediatrics portal account, where you have access to your child’s vaccine record. Our practice has a near 100% on-schedule vaccination rate MMR vaccine, so it would be very unusual if your child is not up to date.
There are situations in which it may be recommended that a child receive the MMR vaccine prior to the 12-Month-old visit, and this is primarily indicated if a child has had direct exposure to a person with the measles , and certain travel situations in which the child will be going to an area with a high prevalence of measles.
The earliest a child can receive the MMR vaccine is 6 months of age. Although vaccinating a child at an age under 12 months has been found to be somewhat effective, protocols which optimize the protective immunity of the MMR vaccine necessitate that a child who receives an MMR vaccine prior to the age of 12 months also then receive the MMR vaccine again at 12 months of age, in order to ensure the greatest likelihood of high protective immunity.
Measles is one of the most contagious diseases on earth. We are monitoring the situation as it evolves.
